Quarterly ResultJul 28, 2026, 02:16 PM
CTS Q2 Net Sales $144.8M, Net Earnings $19.2M, Diluted EPS $0.66
AI Summary
CTS Corp reported increased financial results for the second quarter of 2026, with net sales rising to $144.8 million and net earnings reaching $19.2 million. Diluted EPS also saw an increase to $0.66. For the first half of 2026, net sales grew to $284.0 million, and net earnings climbed to $36.4 million. The company also reached an agreement in principle for an environmental settlement of $7.61 million, with its portion estimated at $6.71 million, and continues to operate under a $300 million revolving credit facility.
Key Highlights
- Q2 2026 net sales increased to $144.8 million from $135.3 million year-over-year.
- Q2 2026 net earnings rose to $19.2 million from $18.5 million year-over-year.
- Q2 2026 diluted EPS grew to $0.66 from $0.62 year-over-year.
- H1 2026 net sales increased to $284.0 million from $261.1 million year-over-year.
- H1 2026 net cash provided by operating activities was $50.7 million, up from $43.9 million.
- Agreed in principle to a $7.61 million environmental settlement, with CTS's portion at $6.71 million.
- Industrial segment revenue increased to $39.5 million in Q2 2026 from $34.1 million year-over-year.
- Medical segment revenue increased to $27.8 million in Q2 2026 from $19.2 million year-over-year.
Price Impact
More from CTS